Wednesday, May 31, 2023 | Back issues
Courthouse News Service Courthouse News Service

Prescription Drug

NEW ORLEANS - In a federal class action, a woman claims she suffered two heart attacks from taking Xanodyne Pharmaceuticals' drug Darvocet (propoxyphene), which did not even kill pain as it was supposed to, and which Xanodyne knew had been "subject to safety concerns for decades."

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.